712 filings
EFFECT
TENX
Tenax Therapeutics Inc
15 Apr 24
Notice of effectiveness
12:15am
EFFECT
TENX
Tenax Therapeutics Inc
15 Apr 24
Notice of effectiveness
12:15am
POS AM
TENX
Tenax Therapeutics Inc
11 Apr 24
Prospectus update (post-effective amendment)
4:59pm
POS AM
TENX
Tenax Therapeutics Inc
11 Apr 24
Prospectus update (post-effective amendment)
4:56pm
10-K
2023 FY
TENX
Tenax Therapeutics Inc
Annual report
28 Mar 24
2:02pm
8-K
TENX
Tenax Therapeutics Inc
28 Mar 24
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
8:45am
424B3
TENX
Tenax Therapeutics Inc
26 Feb 24
Prospectus supplement
4:31pm
424B3
TENX
Tenax Therapeutics Inc
26 Feb 24
Prospectus supplement
4:31pm
8-K
TENX
Tenax Therapeutics Inc
23 Feb 24
Other Events
4:30pm
424B3
TENX
Tenax Therapeutics Inc
21 Feb 24
Prospectus supplement
4:32pm
424B3
TENX
Tenax Therapeutics Inc
21 Feb 24
Prospectus supplement
4:30pm
SC 13G
S.H.N. Financial Investments Ltd.
20 Feb 24
TENAX THERAPEUTICS / S.H.N. Financial Investments ownership change
4:01pm
8-K
TENX
Tenax Therapeutics Inc
20 Feb 24
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
8:33am
SC 13G
TENX
Tenax Therapeutics Inc
16 Feb 24
TENAX THERAPEUTICS / CVI Investments ownership change
11:28am
SC 13G
Lind Global Fund II LP
15 Feb 24
TENAX THERAPEUTICS / Lind Global Fund II ownership change
7:36pm
SC 13G/A
Armistice Capital, LLC
14 Feb 24
TENAX THERAPEUTICS / ARMISTICE CAPITAL ownership change
2:58pm
424B3
TENX
Tenax Therapeutics Inc
13 Feb 24
Prospectus supplement
4:32pm
8-K
TENX
Tenax Therapeutics Inc
12 Feb 24
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
4:46pm
424B4
TENX
Tenax Therapeutics Inc
9 Feb 24
Prospectus supplement with pricing info
5:00pm
424B3
TENX
Tenax Therapeutics Inc
8 Feb 24
Prospectus supplement
4:51pm